ES
CHAQ.WS

Equitec Specialists’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Equitec Specialists’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,188
Closed -$24K – 195
2021
Q1 		$24K Sell
25,188
-25,260
-50% -$28K ﹤0.01% 178
2020
Q4 		$50K Buy
50,448
+40,448
+404% +$30.6K ﹤0.01% 167
2020
Q3 		$7K Buy
+10,000
New +$6.99K ﹤0.01% 157

Other funds holding CHAQ.WS

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Equitec Specialists's CHAQ.WS Position: Q2 2021 in Review

Equitec Specialists sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q2 2021, closing a stake of 25,188 shares — an estimated $24K sold.

Equitec Specialists first reported a position in CHAQ.WS in Q3 2020 and held it in 3 quarters. The position peaked at $50K in Q4 2020. 21 funds tracked by Wall St. Rank hold CHAQ.WS as of Q2 2021.

  • Equitec Specialists reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 25,188 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q2 2021, an estimated $24K.
  • Equitec Specialists first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 3 quarters.
  • Equitec Specialists's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $50K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.